Oryx Token (ORX)

The Future Of Decentralization In E-Commerce

Review Score
ICO Price
0.05 USD
Pre ICO Price
0.022 USD
Soft Cap
Hard Cap
Pre ICO Start Date
10 June 2019
Pre ICO End Date
22 June 2019
Start Date
10 August 2019
End Date
15 September 2019

What is Oryx Token?

E-commerce in the Middle East is growing, there are numbers of large players in this business, such as traders, brokers, banks, insurance companies and public institutions both national and in international firms.

The Oryx Project upholds an ambitious set of goals stated In The Roadmap But Yet Manageable.

The Roadmap Is A Dynamic List Of The Aspirations Of The Project And The Community.

The Oryx Team Will Maintain A  Roadmap That Is Malleable but Also Feasible in Order To Focus On The Essential Components Of The Project While Leaving Some Wiggle Room For Necessary Adaptations.

Decentralization Of E-Commerce in the Middle East To The World at large, this is our goal and our vision.

Oryx works on collective adoption of token usage in real-world applications. (Exchange platform, Store, Crypto games, Crypto platform and E-commerce generally).

Oryx main objectives is to provide a Token (ORX) to our partners and act as an intermediary body which accept cryptocurrency, to transfer funds and payments within our platforms.

Information displayed on CoinCheckup can be updated by the respective ICOs and/or Crypto representatives and does not present the opinion of CoinCheckup.com and/or the CoinCheckup team.

Trading and investing in digital assets is highly speculative and comes with many risks. The analysis/stats on CoinCheckup.com and it’s subsites are for informational purposes and should not be considered investment advice and or the truth. Statements and financial information on CoinCheckup.com and it’s subsites should not be construed as an endorsement or recommendation to buy, sell or hold.

Please do your own research on all of your investments carefully. Scores are based on averages of third party websites.  Past performance is no indicative of future results. Read the full disclaimer here.